NY S08991 | 2023-2024 | General Assembly
Status
Spectrum: Bipartisan Bill
Status: Introduced on April 8 2024 - 25% progression
Action: 2024-06-03 - PRINT NUMBER 8991A
Pending: Senate Alcoholism and Substance Use Disorders Committee
Text: Latest bill text (Amended) [HTML]
Status: Introduced on April 8 2024 - 25% progression
Action: 2024-06-03 - PRINT NUMBER 8991A
Pending: Senate Alcoholism and Substance Use Disorders Committee
Text: Latest bill text (Amended) [HTML]
Summary
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.
Title
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.
Sponsors
| Sen. Peter Harckham [D] | Sen. Jacob Ashby [R] | Sen. Jeremy Cooney [D] | Sen. Patrick Gallivan [R] |
| Sen. Peter Oberacker [R] | Sen. James Skoufis [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-06-03 | Senate | PRINT NUMBER 8991A |
| 2024-06-03 | Senate | AMEND AND RECOMMIT TO ALCOHOLISM AND SUBSTANCE USE DISORDERS |
| 2024-04-08 | Senate | REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS |
Same As/Similar To
A08075 (Same As) 2024-06-07 - REFERRED TO RULES
